Invention Grant
- Patent Title: Anhydrous lenalidomide form-I
- Patent Title (中): 无水来那度胺I型
-
Application No.: US13581872Application Date: 2010-03-08
-
Publication No.: US08877932B2Publication Date: 2014-11-04
- Inventor: Durga Prasad Konakanchi , Buchappa Gongalla , Kotayya Babu Sikha , Chandrasekar Kandaswamy , Kali Satya Bhujanga Rao Adibhatla , Venkaiah Chowdary Nannapaneni
- Applicant: Durga Prasad Konakanchi , Buchappa Gongalla , Kotayya Babu Sikha , Chandrasekar Kandaswamy , Kali Satya Bhujanga Rao Adibhatla , Venkaiah Chowdary Nannapaneni
- Applicant Address: IN Banjara Hills, Hyderabad
- Assignee: Natco Pharma Limited
- Current Assignee: Natco Pharma Limited
- Current Assignee Address: IN Banjara Hills, Hyderabad
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/IN2010/000128 WO 20100308
- International Announcement: WO2011/111053 WO 20110915
- Main IPC: C07D401/00
- IPC: C07D401/00 ; A61K31/445 ; C07D401/04
Abstract:
Anhydrous polymorphic form-I of anti cancer drug, Lenalidomide whose chemical name is 3-(4-amino-1-oxo-1, 3-dihydro-isoindole-2-yl)-piperidine-2,6-dione, is disclosed. Alternate methods for making anhydrous polymorphic form-I of Lenalidomide are also disclosed.
Public/Granted literature
- US20130059889A1 ANHYDROUS LENALIDOMIDE FORM-I Public/Granted day:2013-03-07
Information query
